Related Experiment Video
Updated: Jul 14, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Inpatient burden of COVID-19 in Japan: A retrospective cohort study
Kathleen M Andersen1, Matthew A Brouillette1, Kanae Togo2
1Pfizer Inc., 66 Hudson Boulevard East, New York, NY, 10001, United States.
Insights
COVID-19 hospitalizations in Japan show a greater burden than influenza, with longer stays, more intensive care unit admissions, and higher mortality. Continued prevention and treatment are crucial to mitigate severe COVID-19 disease.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Healthcare Management
Background:
- Changing COVID-19 dynamics and vaccine access in Japan necessitate updated data on severe disease burden.
- This study analyzes inpatient healthcare resource utilization for COVID-19 in Japan, comparing it with influenza.
Purpose of the Study:
- To describe the inpatient healthcare resource utilization of COVID-19 in Japan.
- To contextualize the burden of severe COVID-19 disease by comparing it with influenza.
Main Methods:
- Retrospective analysis of hospitalized COVID-19 and influenza cases from a large Japanese hospital database (Medical Data Vision).
- Data collection spanned April 2020–January 2024 for COVID-19 and November 2017–October 2019 for influenza.
- Key outcomes included length of stay, ICU admission, invasive mechanical ventilation (IMV), and inpatient mortality, stratified by age and time.
Main Results:
- COVID-19 patients were older (median 80 vs 64 years) and had significantly longer hospital stays (21 vs 5 days) compared to influenza patients.
- Higher proportions of COVID-19 patients required ICU admission (3% vs 1%), IMV (6% vs 3%), and experienced in-hospital mortality (12% vs 3%).
- COVID-19's inpatient burden exceeded influenza's for both adult and pediatric populations, with recent data (May 2023–January 2024) showing a disproportionately higher burden.
Conclusions:
- COVID-19 imposes a substantial inpatient healthcare burden in Japan, exceeding that of influenza across key metrics.
- Findings highlight the ongoing need for robust COVID-19 prevention strategies and effective treatments to reduce severe disease outcomes.
Background:
Changing disease dynamics and access to COVID-19 vaccines in Japan warrant a timely description of the burden of severe disease. Here we report inpatient healthcare resource utilization of COVID-19 in Japan and contextualize results with influenza.
Methods:
We selected persons hospitalized for COVID-19 (ICD-10 code U07.1) from April 1, 2020-January 31, 2024 or influenza (ICD-10 code J09.X-J11.x) from November 1, 2017-October 31, 2019 from Medical Data Vision, a large hospital-based database in Japan. Outcomes of interest were length of stay, intensive care unit (ICU) admission, receipt of invasive mechanical ventilation (IMV), and inpatient mortality, assessed overall, as well as stratified by age groups and calendar time.
Findings:
Among 5684 hospitalized COVID-19 cases, persons were older (median age 80 vs 64) and had a longer length of stay (median 21 vs 5 days) than the 18,584 influenza cases. The proportions of COVID-19 patients admitted to ICU (3% vs 1%), received IMV (6% vs 3%) and died in hospital (12% vs 3%) were higher compared to those of influenza patients. Burden was higher in adult COVID-19 patients than pediatric COVID-19 patients; however, COVID-19 burden surpassed influenza burden for both adults and pediatric patients. Inpatient burden of COVID-19 between May 2023 and January 2024 remained greater than that of influenza, with five times longer length of stay, three times the frequency of ICU care, twice the IMV support and four times the in-hospital deaths.
Interpretation:
These findings underscore the need for continued prevention and treatment of COVID-19 to prevent severe disease.
More Related Videos
Related Concept Videos
Pareto Chart
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Confounding in Epidemiological Studies
Bias in Epidemiological Studies
Investigation of Disease Outbreaks
Coronavirus

